Invention Grant
- Patent Title: Dried implant composition and injectable aqueous implant formulation
-
Application No.: US16220306Application Date: 2018-12-14
-
Publication No.: US10695461B2Publication Date: 2020-06-30
- Inventor: Daniel Suppiger , Paul Buxton , Nino Kurz
- Applicant: GEISTLICH PHARMA AG
- Applicant Address: CH Wolhusen
- Assignee: Geistlich Pharma AG
- Current Assignee: Geistlich Pharma AG
- Current Assignee Address: CH Wolhusen
- Agency: Rothwell, Figg, Ernst & Manbeck, P.C.
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@2df8a9ae
- Main IPC: A61L27/24
- IPC: A61L27/24 ; A61L27/46 ; A61L27/50 ; A61L24/00

Abstract:
A dried implant composition for preparing an injectable aqueous implant formulation that is extrudable through a tapering system and a gauge 18 cannula, including a mixture of nanocrystalline hydroxyapatite particles derived from natural bone having a size of 50 to 200 μm and fragments of naturally crosslinked fibrous collagen material that pass through a 0.5 mm sieve; an injectable aqueous implant formulation for use in a method of oral tissue regeneration, wherein the injectable aqueous implant formulation is obtainable by hydration and homogeneous mixing; a process for preparing the injectable aqueous implant formulation; and a kit for preparing the injectable aqueous implant formulation for use in oral tissue regeneration.
Public/Granted literature
- US20190209735A1 DRIED IMPLANT COMPOSITION AND INJECTABLE AQUEOUS IMPLANT FORMULATION Public/Granted day:2019-07-11
Information query